bright meds tirzepatide reviews Brightmeds: Compound Safety Information Fridays Compounded Tirzepatide Review: $359/mo

Retatrutide actually creates an opportunity to restart an exercise routine with less discomfort

Flanagan for sharing expertise in medicinal chemistry

others emphasize comprehensive support

Metabolic Acidosis: Measure electrolytes before and during treatment

Tirzepatide SURMOUNT-1 (2022) and SURPASS-2 (2021) SURMOUNT-1 (Jastreboff et al., NEJM 2022): 2,539 non-diabetic adults with BMI 30, 72 weeks of tirzepatide 15 mg/week: Weight loss: 20.9% (vs 3.1% placebo) 91% of participants 5% loss, 56.7% 20% SURPASS-2 (Fras et al., NEJM 2021): 1,879 T2D patients head-to-head vs semaglutide 1 mg: HbA1c: 2.30% (tirzepatide 15 mg) vs 1.86% (semaglutide) Weight loss: 11.2 kg vs 5.7 kg Tirzepatide statistically outperforms semaglutide on both HbA1c and weight in a head-to-head trial a rare outcome in incretin pharmacology